×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 9 Plenary: AI: Investments and Future Outcomes
Session Chair(s)
Oxana Iliach, PhD
Senior Director Regulatory Strategy
Certara, Canada
Marcia Sam
Senior Manager, Regulatory Affairs
Regeneron Canada Company, Canada
This session will provide an overview of Health Canada current view on use of AI and potential future outcomes.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe potential use of AI
- Discuss investments in AI development
- Explain latest Health Canada expectations for AI outcomes
Speaker(s)
AI: Regulatory Reflections
Kelly Robinson, MSc
Health Canada, Canada
Director General, Marketed Health Products Directorate
PIC/S Working Group on AI: International Collaboration of Pharmacovigilance Inspectors
Myriam Salem, MSc
Health Canada, Canada
Good Pharmacovigilance Practices National Coordinator
Leveraging AI at Health Canada (HC)
James Van Loon
Health Canada, Canada
Chief Data Officer, Digital Transformation Branch
Have an account?